Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001182616-03-000001
Filing Date
2003-05-01
Accepted
2003-05-01 16:35:03
Documents
1
Period of Report
2003-04-29

Document Format Files

Seq Description Document Type Size
1 afnfrm4.txt 4 5487
  Complete submission text file 0001182616-03-000001.txt   7465
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-20720 | Film No.: 03677238
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LIGAND PHARMACEUTICALS INC., 10275 SCIENCE CENTER DR. SAN DIEGO CA 92121
Business Address C/O LIGAND PHARMACEUTICALS INC., 10275 SCIENCE CENTER DR. SAN DIEGO CA 92121 8585507577
NEGRO-VILAR ANDRES (Reporting) CIK: 0001182616 (see all company filings)